HTSUF
Price
$28.94
Change
-$3.36 (-10.40%)
Updated
Jun 10 closing price
Capitalization
2.06B
INIS
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
46.37M
Interact to see
Advertisement

HTSUF vs INIS

Header iconHTSUF vs INIS Comparison
Open Charts HTSUF vs INISBanner chart's image
Hisamitsu Pharmaceutical
Price$28.94
Change-$3.36 (-10.40%)
Volume$100
Capitalization2.06B
International Isotopes
Price$0.09
Change-$0.00 (-0.00%)
Volume$20.44K
Capitalization46.37M
HTSUF vs INIS Comparison Chart in %
Loading...
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HTSUF vs. INIS commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUF is a Hold and INIS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (HTSUF: $28.94 vs. INIS: $0.09)
Brand notoriety: HTSUF and INIS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HTSUF: 100% vs. INIS: 15%
Market capitalization -- HTSUF: $2.06B vs. INIS: $46.37M
HTSUF [@Pharmaceuticals: Generic] is valued at $2.06B. INIS’s [@Pharmaceuticals: Generic] market capitalization is $46.37M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUF’s FA Score shows that 0 FA rating(s) are green whileINIS’s FA Score has 1 green FA rating(s).

  • HTSUF’s FA Score: 0 green, 5 red.
  • INIS’s FA Score: 1 green, 4 red.
According to our system of comparison, INIS is a better buy in the long-term than HTSUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUF’s TA Score shows that 0 TA indicator(s) are bullish while INIS’s TA Score has 3 bullish TA indicator(s).

  • HTSUF’s TA Score: 0 bullish, 1 bearish.
  • INIS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HTSUF is a better buy in the short-term than INIS.

Price Growth

HTSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while INIS (@Pharmaceuticals: Generic) price change was -17.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HTSUF($2.07B) has a higher market cap than INIS($46.4M). INIS YTD gains are higher at: 156.105 vs. HTSUF (17.839). HTSUF has higher annual earnings (EBITDA): 26.4B vs. INIS (779K). HTSUF has more cash in the bank: 123B vs. INIS (1.65M). INIS has less debt than HTSUF: INIS (4.9M) vs HTSUF (1.12B). HTSUF has higher revenues than INIS: HTSUF (150B) vs INIS (14.2M).
HTSUFINISHTSUF / INIS
Capitalization2.07B46.4M4,450%
EBITDA26.4B779K3,388,960%
Gain YTD17.839156.10511%
P/E Ratio15.98N/A-
Revenue150B14.2M1,056,338%
Total Cash123B1.65M7,472,661%
Total Debt1.12B4.9M22,791%
FUNDAMENTALS RATINGS
HTSUF vs INIS: Fundamental Ratings
HTSUF
INIS
OUTLOOK RATING
1..100
4386
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
6887
SMR RATING
1..100
8390
PRICE GROWTH RATING
1..100
5437
P/E GROWTH RATING
1..100
765
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INIS's Valuation (85) in the null industry is in the same range as HTSUF (92). This means that INIS’s stock grew similarly to HTSUF’s over the last 12 months.

HTSUF's Profit vs Risk Rating (68) in the null industry is in the same range as INIS (87). This means that HTSUF’s stock grew similarly to INIS’s over the last 12 months.

HTSUF's SMR Rating (83) in the null industry is in the same range as INIS (90). This means that HTSUF’s stock grew similarly to INIS’s over the last 12 months.

INIS's Price Growth Rating (37) in the null industry is in the same range as HTSUF (54). This means that INIS’s stock grew similarly to HTSUF’s over the last 12 months.

INIS's P/E Growth Rating (5) in the null industry is significantly better than the same rating for HTSUF (76). This means that INIS’s stock grew significantly faster than HTSUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HTSUFINIS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
12%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
15%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
26%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRSRX29.990.08
+0.27%
Russell Inv Global Real Estate Secs R6
TSAMX14.42-0.01
-0.07%
Thornburg Summit A
MEIJX51.79-0.25
-0.48%
MFS Value R4
MLPGX6.97-0.04
-0.57%
Invesco SteelPath MLP Alpha C
DVLRX62.62-0.57
-0.90%
Macquarie Small Cap Value R

HTSUF and

Correlation & Price change

A.I.dvisor tells us that HTSUF and INIS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUF and INIS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
INIS - HTSUF
10%
Poorly correlated
+3.65%
INDV - HTSUF
5%
Poorly correlated
+1.25%
IPSEF - HTSUF
4%
Poorly correlated
N/A
GTBIF - HTSUF
3%
Poorly correlated
-12.40%
HLTRF - HTSUF
1%
Poorly correlated
+0.27%
More

INIS and

Correlation & Price change

A.I.dvisor tells us that INIS and HSTI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HSTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
+3.65%
HSTI - INIS
10%
Poorly correlated
N/A
HTSUF - INIS
10%
Poorly correlated
N/A
IPSEY - INIS
7%
Poorly correlated
N/A
GRUSF - INIS
7%
Poorly correlated
-3.00%
KHTRF - INIS
3%
Poorly correlated
N/A
More